Paradigmshift you posted:
"rights issue might still go ahead. no merger talks or takeovers. they do not pressure customers to pay promptly so cash flow is an issue."
Could you please substantiate these claims.
The announcement to the market on the 2nd March specifically says: "The Company is in current discussions with another entity concerning possible partnering or merger opportunities."
You said "no merger talks or takeovers." This means the ITE has mislead the market from their announcement. Are you willing to stand by your statement, as this is quite a serious accusation you are making.
Same goes for "they do not pressure customers to pay promptly so cash flow is an issue"
Appreciate your post "rights issue might still go ahead. no merger talks or takeovers. they do not pressure customers to pay promptly so cash flow is an issue."
Could you please substantiate these claims.
The announcement to the market on the 2nd March specifically says: "The Company is in current discussions with another entity concerning possible partnering or merger opportunities."
You said "no merger talks or takeovers." This means the ITE has mislead the market from their announcement. Are you willing to stand by your statement, as this is quite a serious accusation you are making.
Same goes for "they do not pressure customers to pay promptly so cash flow is an issue"
Appreciate your post Paradigmshift as long as you can substantiate your claims.
Sorry about the confusion Phil.
- Forums
- ASX - By Stock
- another razor success
ITE
i.t.& e limited
Paradigmshift you posted:"rights issue might still go ahead. no...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online